Financial Year |
March 31 2023 |
Monetary Funds |
47,497,449,000.00 |
Held-for-trading Financial Assets |
12,825,440,000.00 |
Notes Receivable |
20,033,274,000.00 |
Accounts Receivable |
83,591,990,000.00 |
Advances to Suppliers |
8,862,232,000.00 |
Other Receivables |
3,626,964,000.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
74,600,339,000.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
6,399,491,000.00 |
Other Current Assets |
5,467,234,000.00 |
Total Current Assets |
293,222,486,000.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
11,092,448,000.00 |
Long-term Equity Investment |
18,427,663,000.00 |
Investment Properties |
1,019,421,000.00 |
Fixed Assetes |
59,467,208,000.00 |
Under-construction Projects |
4,480,218,000.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
15,930,264,000.00 |
R&D expenses |
833,982,000.00 |
Goodwill |
258,237,000.00 |
Long-Term Deferred and Prepaid Expenses |
264,956,000.00 |
Deferred Income Tax Assets |
3,665,729,000.00 |
Other Non-Current Assets |
33,503,381,000.00 |
Sub-Total of Non-Current Assets |
155,166,807,000.00 |
Total Assets |
448,389,293,000.00 |
Short-Term Loans |
13,261,890,000.00 |
Trading Financial liabilities |
37,509,000.00 |
Notes Payable |
28,337,118,000.00 |
Accounts Payable |
131,236,783,000.00 |
Accounts Received In Advance |
33,917,000.00 |
Employee Compensation Payable |
2,061,936,000.00 |
Taxes Payable |
1,217,269,000.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
15,451,860,000.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
5,447,030,000.00 |
Other Current Liabilities |
9,243,223,000.00 |
Sub-Total of Current Liabilities |
232,194,501,000.00 |
Long-term Loans |
6,396,157,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
38,680,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
7,273,730,000.00 |
Deferred Income Tax Liabilities |
368,744,000.00 |
Other Non-Current Liabilities |
108,277,000.00 |
Sub-Total of Non-Current Liabilities |
24,169,906,000.00 |
Total Liabilities |
256,364,407,000.00 |
Paid-In Capital(Or Share Stock) |
28,698,864,000.00 |
Capital Surplus |
41,333,927,000.00 |
Surplus Reserve |
5,491,912,000.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
80,056,703,000.00 |
Minority Stockholder's Interest |
36,354,370,000.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
155,670,516,000.00 |
Owner's Equity(Stockholder's Equity) |
192,024,886,000.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
448,389,293,000.00 |